239
Views
13
CrossRef citations to date
0
Altmetric
Research Article

Specific immunoglobulin isotypes correlate with disease activity, morphology, duration and HLA association in Pemphigus vulgaris

, &
Pages 516-526 | Received 22 Aug 2011, Accepted 10 Jun 2012, Published online: 17 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ali Nili, Ali Salehi Farid, Masoud Asgari, Soheil Tavakolpour, Hamidreza Mahmoudi & Maryam Daneshpazhooh. (2021) Current status and prospects for the diagnosis of pemphigus vulgaris. Expert Review of Clinical Immunology 17:8, pages 819-834.
Read now
Nicola Cirillo, Emad AlShwaimi, Michael McCullough & Stephen S. Prime. (2014) Pemphigus vulgaris autoimmune globulin induces Src-dependent tyrosine-phosphorylation of plakophilin 3 and its detachment from desmoglein 3. Autoimmunity 47:2, pages 134-140.
Read now

Articles from other publishers (11)

Ines Lakoš Jukić, Mislav Mokos & Branka Marinović. (2023) HLA class II antigens in Croatian patients with pemphigus vulgaris and their correlation with anti-desmoglein antibodies. Frontiers in Immunology 14.
Crossref
Randa Mohammed Youssef, Marwah Adly Saleh, Mona Mostafa Korany, Zeinab A. Nour & Mona El‐Kalioby. (2022) Assessment of tissue E‐cadherin and its proteolytic serum fragment in pemphigus vulgaris before and after remission: A case–control study. Journal of Cosmetic Dermatology 21:11, pages 6343-6350.
Crossref
Y.‐Y. Sung, Y.‐T. Cho & C.‐Y. Chu. (2022) Cutaneous‐type pemphigus vulgaris might be a transient subtype in pemphigus vulgaris: a case series. Journal of the European Academy of Dermatology and Venereology 36:11.
Crossref
Marie-Laure Golinski, Alexandre Lemieux, Maud Maho-Vaillant, Marion Barray, Laurent Drouot, Damien Schapman, Marie Petit, Michael Hertl, Olivier Boyer, Sébastien Calbo, Pascal Joly & Vivien Hébert. (2022) The Diversity of Serum Anti-DSG3 IgG Subclasses Has a Major Impact on Pemphigus Activity and Is Predictive of Relapses After Treatment With Rituximab. Frontiers in Immunology 13.
Crossref
Sue‐Ching Yeoh, Karen Byth‐Wilson, Dedee F. Murrell, Mark Schifter, Ming‐Wei Lin & David A. Fulcher. (2019) Pemphigus vulgaris disease activity: The role of antibodies to desmogleins and their isotype. Journal of Oral Pathology & Medicine 48:7, pages 619-625.
Crossref
Megan McSherry, Katherine E. Masih, Nursel H. Elcioglu, Pelin Celik, Ozge Balci, Filiz Basak Cengiz, Daniella Nunez, Claire J. Sineni, Serhat Seyhan, Defne Kocaoglu, Shengru Guo, Duygu Duman, Guney Bademci & Mustafa Tekin. (2018) Identification of candidate gene FAM183A and novel pathogenic variants in known genes: High genetic heterogeneity for autosomal recessive intellectual disability. PLOS ONE 13:11, pages e0208324.
Crossref
Khalaf Kridin & Reuven Bergman. (2018) The Usefulness of Indirect Immunofluorescence in Pemphigus and the Natural History of Patients With Initial False-Positive Results: A Retrospective Cohort Study. Frontiers in Medicine 5.
Crossref
Soheil Tavakolpour & Vahid Tavakolpour. (2016) Interleukin 4 inhibition as a potential therapeutic in pemphigus. Cytokine 77, pages 189-195.
Crossref
Danka Svecova, Zuzana Parnicka, Lucia Pastyrikova, Slavomir Urbancek, Jan Luha & Milan Buc. (2015) HLA DRB1* and DQB1* alleles are associated with disease severity in patients with pemphigus vulgaris. International Journal of Dermatology 54:2, pages 168-173.
Crossref
Emanual Maverakis, Kyoungmi Kim, Michiko Shimoda, M. Eric Gershwin, Forum Patel, Reason Wilken, Siba Raychaudhuri, L. Renee Ruhaak & Carlito B. Lebrilla. (2015) Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review. Journal of Autoimmunity 57, pages 1-13.
Crossref
M Cornillet, M Sebbag, E Verrouil, A Magyar, F Babos, A Ruyssen-Witrand, F Hudecz, A Cantagrel, G Serre & L Nogueira. (2014) The fibrin-derived citrullinated peptide β60–74Cit 60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies . Annals of the Rheumatic Diseases 73:6, pages 1246-1252.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.